White-matter-nulled MPRAGE at 7T reveals thalamic lesions and atrophy of specific thalamic nuclei in multiple sclerosis.


Journal

Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 8 2 2019
medline: 29 7 2021
entrez: 8 2 2019
Statut: ppublish

Résumé

Investigating the degeneration of specific thalamic nuclei in multiple sclerosis (MS) remains challenging. White-matter-nulled (WMn) MPRAGE, MP-FLAIR, and standard T1-weighted magnetic resonance imaging (MRI) were performed on MS patients ( WMn-MPRAGE showed more thalamic MS lesions ( WMn-MPRAGE and automatic thalamic segmentation can highlight thalamic MS lesions and measure patterns of focal thalamic atrophy.

Sections du résumé

BACKGROUND
Investigating the degeneration of specific thalamic nuclei in multiple sclerosis (MS) remains challenging.
METHODS
White-matter-nulled (WMn) MPRAGE, MP-FLAIR, and standard T1-weighted magnetic resonance imaging (MRI) were performed on MS patients (
RESULTS
WMn-MPRAGE showed more thalamic MS lesions (
CONCLUSION
WMn-MPRAGE and automatic thalamic segmentation can highlight thalamic MS lesions and measure patterns of focal thalamic atrophy.

Identifiants

pubmed: 30730233
doi: 10.1177/1352458519828297
pmc: PMC6685761
mid: NIHMS1518662
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

987-992

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB015891
Pays : United States

Références

Cell Mol Life Sci. 2015 Mar;72(6):1127-47
pubmed: 25417212
Mult Scler. 2018 Oct;24(11):1433-1444
pubmed: 28803512
Magn Reson Med. 2015 May;73(5):1786-94
pubmed: 24889754
Hum Brain Mapp. 2015 Jul;36(7):2809-25
pubmed: 25873194
Brain Struct Funct. 2017 Jul;222(5):2203-2216
pubmed: 27888345
Mult Scler. 2015 Aug;21(9):1139-50
pubmed: 25583851
Hum Brain Mapp. 2018 Apr;39(4):1814-1824
pubmed: 29331060
Invest Radiol. 2014 May;49(5):290-8
pubmed: 24566291
Mult Scler. 2016 Sep;22(10):1327-36
pubmed: 26541795
Neuroimage. 2004 Apr;21(4):1428-42
pubmed: 15050568
Radiology. 2015 Dec;277(3):784-92
pubmed: 26043265
Neuroimage. 2014 Jan 1;84:534-45
pubmed: 24018302
Neurology. 2013 Jan 8;80(2):210-9
pubmed: 23296131

Auteurs

Vincent Planche (V)

Institut des Maladies Neurodégénératives, CNRS UMR 5293, Bordeaux, France; University of Bordeaux, Bordeaux, France; CHU de Bordeaux, Bordeaux, France.

Jason H Su (JH)

Department of Electrical Engineering, Stanford University, Stanford, CA, USA.

Sandy Mournet (S)

CHU de Bordeaux, Bordeaux, France.

Manojkumar Saranathan (M)

Department of Medical Imaging, The University of Arizona, Tucson, AZ, USA.

Vincent Dousset (V)

University of Bordeaux, Bordeaux, France; CHU de Bordeaux, Bordeaux, France; INSERM U1215, Neurocentre Magendie, Bordeaux, France.

May Han (M)

Department of Neurology, School of Medicine, Stanford University, Palo Alto, CA, USA.

Brian K Rutt (BK)

Department of Radiology, Stanford University, Stanford, CA, USA.

Thomas Tourdias (T)

University of Bordeaux, Bordeaux, France; CHU de Bordeaux, Bordeaux, France; INSERM U1215, Neurocentre Magendie, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH